IRIS
GEBBIA, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.680
AS - Asia 3.275
EU - Europa 1.944
SA - Sud America 1.165
AF - Africa 82
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.149
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.567
SG - Singapore 1.599
IE - Irlanda 1.057
BR - Brasile 979
HK - Hong Kong 874
VN - Vietnam 287
IT - Italia 207
DE - Germania 170
CN - Cina 157
GB - Regno Unito 151
TR - Turchia 92
FR - Francia 87
AR - Argentina 74
CA - Canada 60
BD - Bangladesh 54
IN - India 49
MX - Messico 44
FI - Finlandia 41
EC - Ecuador 40
CH - Svizzera 37
ZA - Sudafrica 33
NL - Olanda 31
ID - Indonesia 28
IQ - Iraq 27
RU - Federazione Russa 24
SE - Svezia 22
MA - Marocco 20
PL - Polonia 19
AT - Austria 16
JP - Giappone 16
PY - Paraguay 16
ES - Italia 15
UA - Ucraina 15
CZ - Repubblica Ceca 14
VE - Venezuela 13
PK - Pakistan 11
CO - Colombia 10
LT - Lituania 10
UY - Uruguay 9
UZ - Uzbekistan 9
CL - Cile 8
PE - Perù 8
BO - Bolivia 7
KR - Corea 7
KZ - Kazakistan 7
SA - Arabia Saudita 7
EG - Egitto 6
IL - Israele 6
JO - Giordania 6
AL - Albania 5
LB - Libano 5
NP - Nepal 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
KE - Kenya 4
PH - Filippine 4
SN - Senegal 4
BE - Belgio 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
RO - Romania 3
AM - Armenia 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CR - Costa Rica 2
HN - Honduras 2
IR - Iran 2
KW - Kuwait 2
LV - Lettonia 2
OM - Oman 2
PS - Palestinian Territory 2
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.149
Salva come PNG Salva come JPEG
Città #
Dallas 3.210
Dublin 1.051
Hong Kong 870
Singapore 790
Boardman 376
Ashburn 349
The Dalles 349
Santa Clara 326
Ho Chi Minh City 113
London 98
São Paulo 94
Istanbul 73
Los Angeles 62
Hanoi 60
Assago 56
Munich 54
Chicago 38
Rio de Janeiro 37
Zurich 37
Helsinki 36
Milan 35
Beijing 27
Prineville 26
Belo Horizonte 25
Brooklyn 24
Fort Worth 24
Frankfurt am Main 24
Montreal 24
Chandler 23
New York 23
Amsterdam 20
Boston 20
Johannesburg 20
San Francisco 18
Quito 17
Springfield 17
Brasília 16
Curitiba 16
Haiphong 16
Naples 16
Tokyo 16
Atlanta 15
Biên Hòa 15
Phoenix 15
Porto Alegre 15
Stockholm 15
Warsaw 15
Catania 14
Denver 14
Guayaquil 13
Mexico City 13
Chennai 12
Ottawa 12
Washington 12
Baghdad 11
Guarulhos 11
Dhaka 10
Seattle 10
Berlin 9
Brno 9
Hải Dương 9
Tashkent 9
Ankara 8
Charlotte 8
Düsseldorf 8
Goiânia 8
Juiz de Fora 8
Manaus 8
New Delhi 8
Ninh Bình 8
Nuremberg 8
Shanghai 8
Asunción 7
Campinas 7
Council Bluffs 7
Fortaleza 7
Montevideo 7
Philadelphia 7
Salvador 7
Santo André 7
Thái Nguyên 7
Amman 6
Bauru 6
Campo Grande 6
Da Nang 6
Erbil 6
Itaquaquecetuba 6
Lauterbourg 6
Lima 6
Misilmeri 6
Moscow 6
Recife 6
Rome 6
Seoul 6
Sorocaba 6
São Luís 6
Toronto 6
Vienna 6
Betim 5
Buenos Aires 5
Totale 9.039
Salva come PNG Salva come JPEG
Nome #
112. UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 295
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 273
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 220
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 184
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin plus etoposide in extensive small-cell lung cancer (SCLC) patients The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial 97
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 91
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 86
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 85
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 84
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group 79
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 75
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] 73
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 73
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 73
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 72
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 72
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 72
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study 71
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis 71
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group 70
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 70
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 69
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 69
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 69
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma 69
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 69
5-Fluorouracil and Recombinant Alpha Interferon-2a in the Treatment of Advanced Colorectal Carcinoma: a Dose Optimization Study 69
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 69
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 68
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group 68
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 67
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 66
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 65
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer. 63
5-fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: Results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.) 63
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 62
Gastric metastasis from breast cancer 62
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial 62
Brain Metastasis in Endometrial Cancer: A Systematic Review 60
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 60
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma 57
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients 56
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 55
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 55
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma 55
TOWARD A NEW PROGNOSTIC-THERAPEUTIC INDEX IN GERIATRIC ONCOLOGY 55
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 52
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 51
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial 50
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 50
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 49
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 48
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study 48
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 47
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 47
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 46
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice 45
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer 45
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1 45
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 45
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 45
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 45
Breast Cancer in Two Ex-Votos, A Millennia Apart: Patients' Hope and Faith Expressed Through the Centuries in Votive Offerings 45
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 44
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome 44
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer 43
The Effects of the Macrocyclic Lactone Bryostatin-1 on Leukemic Cells in Vitro 43
Alpha interferon in the treatment of hairy cell leukemia 43
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy 43
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 43
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 43
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603). 43
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 42
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB–IV non-small cell lung carcinoma: a prospective randomized study 42
A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy 42
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 41
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 41
Hydroxyurea modulates 5-fluorouracil antineoplastic activity in advanced head and neck carcinoma pretreated with chemotherapy 41
Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study 41
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 41
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 40
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 40
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 40
Nutritional management of the patient with pancreatic cancer: From the diagnostic and therapeutic pathway to an integrated hospital-territory approach 39
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer 39
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 39
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study. 39
Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity 39
Combination Chemotherapy with Cyclophosphamide, Doxorubicin and Vincristine in the Treatment of Stage III-IV Small-Cell Lung Cancer 38
Vinblastine and Interferon-Alpha-2a Regimen in the Treatment of Metastatic Renal Cell Carcinoma 38
The in vitro effect of the antineoplastic agent bryostatin 4 on human hematopoietic progenitor cells 38
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 38
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale) 38
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society of Medical Oncology (AIOM) 37
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 37
null 37
A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma 37
Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients 37
The Effectiveness of Combination Chemotherapy with Cisplatinum and Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer 37
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells 37
Totale 6.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 0 0 0 0 0 0 5 2 7 2 10
2022/2023174 13 14 4 8 6 13 3 12 8 3 49 41
2023/2024970 39 84 66 77 138 104 158 62 50 52 40 100
2024/20255.303 423 366 528 100 512 470 409 278 757 561 565 334
2025/20266.058 642 2.102 1.788 836 320 370 0 0 0 0 0 0
Totale 12.531